Jianmin Pharmaceutical Group Stock Forecast for 2023 - 2025 - 2030

Updated on 04/28/2024

Stock Rating
18
Price Target
¥87.74
Consensus
Outperform
Upside
57.69%
Analysts
0
Stock Rating
18
Upside
57.69%
Analysts
0
Price Target
¥87.74

Jianmin Pharmaceutical Group Stock Forecast and Price Target

According to experts, who recently provided their 2024 price targets for Jianmin Pharmaceutical Group, the average price target is ¥87.74, with a high estimate of ¥87.74 and a low estimate of ¥87.74. That is a potential upside of approximately 57.69% from the last closing price of ¥55.64 on April, 2024. If you are not interested in 600976 stock, you may still be interested in its competitors and their current standings.

¥87.74

57.69% Upside

Buy
Buy

Jianmin Pharmaceutical Group Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Jianmin Pharmaceutical Group's Price has fallen from ¥87.99 to ¥0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach ¥126.32 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
¥126.32
2025 Fair Value Forecast
¥153.91
2026 Fair Value Forecast
¥185.49
2027 Fair Value Forecast
¥102.05
2028 Fair Value Forecast
¥117.98
2029 Fair Value Forecast
¥138.13
2030 Fair Value Forecast
¥162.84
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600276 Stock Forecast Jiangsu Hengrui Medicine Outperform 15
¥45.61 Buy/Sell ¥56.49 18.40%
T14 Stock Forecast Tianjin Pharmaceutical Da Ren ... Outperform 18
$34.37 Buy/Sell $1.70 33.26%
600436 Stock Forecast Zhangzhou Pientzehuang Pharmac... Outperform 18
¥225.69 Buy/Sell ¥302.86 25.19%
000538 Stock Forecast Yunnan Baiyao Group Co.,Ltd Outperform 18
¥55.33 Buy/Sell ¥65.39 10.25%
1093 Stock Forecast CSPC Pharmaceutical Group Buy 18
HK$6.60 Buy/Sell HK$9.50 40.91%

Jianmin Pharmaceutical Group Revenue Forecast for 2023 - 2025 - 2030

Jianmin Pharmaceutical Group's Revenue has seen impressive growth In the last three years, rising from ¥2.46B to ¥4.21B – a growth of 71.55%. According to 0 analysts, Jianmin Pharmaceutical Group's Revenue will fall by 16.21% in the next year, reaching ¥3.53B. Professionals believe that By 2030, Jianmin Pharmaceutical Group's Revenue will fall to ¥3.61B – a 14.36% decrease from its current value.

2024 Rev Forecast
¥3.53B
2025 Rev Forecast
¥3.48B
2026 Rev Forecast
¥3.56B
2027 Rev Forecast
¥3.78B
2028 Rev Forecast
¥3.70B
2029 Rev Forecast
¥3.63B
2030 Rev Forecast
¥3.61B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000999 Stock Forecast China Resources Sanjiu Medical... Buy 18
¥60.78 Buy/Sell ¥65.95 12.11%
600085 Stock Forecast Beijing Tongrentang Outperform 16
¥42.90 Buy/Sell ¥61.18 25.87%
600196 Stock Forecast Shanghai Fosun Pharmaceutical ... Outperform 16
¥23.19 Buy/Sell ¥33.57 25.70%

Jianmin Pharmaceutical Group Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Jianmin Pharmaceutical Group's Dividend per Share has grown by 224.32%, rising from ¥0.37 to ¥1.20. For the next year, analysts predict that Dividend per Share will reach ¥1.56 – an increase of 30.00%. Over the next seven years, experts believe that Jianmin Pharmaceutical Group's Dividend per Share will grow at a rate of 34.12%.

2024 DPS Forecast
¥1.56
2025 DPS Forecast
¥1.91
2026 DPS Forecast
¥1.54
2027 DPS Forecast
¥1.45
2028 DPS Forecast
¥1.51
2029 DPS Forecast
¥1.64
2030 DPS Forecast
¥1.61
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002294 Stock Forecast Shenzhen Salubris Pharmaceutic... Buy 18
¥31.26 Buy/Sell ¥35.65 18.36%
600079 Stock Forecast Humanwell Healthcare (Group) Buy 0
¥21.37 Buy/Sell ¥32.49 -50.68%
000513 Stock Forecast Livzon Pharmaceutical Group Outperform 18
¥36.98 Buy/Sell ¥39.23 11.41%

Jianmin Pharmaceutical Group Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600518 Stock Forecast Kangmei Pharmaceutical - 6
¥2.00 Buy/Sell ¥25.97 -100.00%
300146 Stock Forecast Byhealth Outperform 15
¥15.65 Buy/Sell ¥26.39 42.24%
900904 Stock Forecast Shanghai Shenqi Pharmaceutical... - 13
$6.30 Buy/Sell $0.00 -100.00%

Jianmin Pharmaceutical Group EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Jianmin Pharmaceutical Group's EBITDA has seen an increase, rising from ¥74.38M to ¥345.27M. This represents a growth of 364.20%. Analysts predict that Jianmin Pharmaceutical Group's EBITDA will increase in the upcoming year, reaching ¥603.30M. This would represent an increase of 74.73%. Over the next seven years, experts predict that Jianmin Pharmaceutical Group's EBITDA will grow at a rate of 148.58%.

2024 EBITDA Forecast
¥0.60B
2025 EBITDA Forecast
¥0.73B
2026 EBITDA Forecast
¥1.05B
2027 EBITDA Forecast
¥0.73B
2028 EBITDA Forecast
¥0.72B
2029 EBITDA Forecast
¥0.76B
2030 EBITDA Forecast
¥0.86B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002262 Stock Forecast Jiangsu Nhwa Pharmaceutical Co... Buy 18
¥24.81 Buy/Sell ¥31.34 24.95%
600380 Stock Forecast Joincare Pharmaceutical Group ... Buy 18
¥11.61 Buy/Sell ¥14.72 26.79%
600062 Stock Forecast China Resources Double-Crane P... Buy 16
¥21.20 Buy/Sell ¥26.00 21.42%

Jianmin Pharmaceutical Group EBIT Forecast for 2023 - 2025 - 2030

Jianmin Pharmaceutical Group's EBIT has seen growth In the last three years, going from ¥53.69M to ¥313.12M – a gain of 483.20% In the next year, analysts believe that EBIT will reach ¥695.30M – an increase of 122.06%. For the next seven years, the forecast is forEBIT to grow by 180.88%.

2024 EBIT Forecast
¥0.70B
2025 EBIT Forecast
¥0.85B
2026 EBIT Forecast
¥1.02B
2027 EBIT Forecast
¥0.72B
2028 EBIT Forecast
¥0.74B
2029 EBIT Forecast
¥0.79B
2030 EBIT Forecast
¥0.88B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600867 Stock Forecast Tonghua Dongbao Pharmaceutical Buy 18
¥10.59 Buy/Sell ¥14.25 42.12%
002773 Stock Forecast Chengdu Kanghong Pharmaceutica... Buy 11
¥20.69 Buy/Sell ¥24.00 -100.00%
603858 Stock Forecast Shandong Buchang Pharmaceutica... - 18
¥16.85 Buy/Sell ¥0.00 -100.00%

Jianmin Pharmaceutical Group EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Jianmin Pharmaceutical Group's EPS has fallen from ¥2.87 to ¥0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach ¥4.12 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
¥4.12
2025 EPS Forecast
¥5.02
2026 EPS Forecast
¥6.05
2027 EPS Forecast
¥3.33
2028 EPS Forecast
¥3.85
2029 EPS Forecast
¥4.51
2030 EPS Forecast
¥5.31
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000623 Stock Forecast Jilin Aodong Pharmaceutical Gr... Buy 16
¥15.28 Buy/Sell ¥0.00 48.36%
600422 Stock Forecast KPC Pharmaceuticals,Inc Buy 18
¥22.53 Buy/Sell ¥28.00 11.01%
000766 Stock Forecast Tonghua Golden-Horse Pharmaceu... - 11
¥17.03 Buy/Sell ¥33.00 -100.00%